PatientsVille.com Logo

PatientsVille

Antineoplastic Side Effects

Common Antineoplastic Side Effects

The most commonly reported Antineoplastic side effects (click to view or check a box to report):

Dyspnoea (10)
Muscular Weakness (5)
Death (5)
Coordination Abnormal (5)
Confusional State (5)
Fatigue (4)
Renal Impairment (4)
Febrile Neutropenia (4)
Hyponatraemia (3)
Dehydration (3)
Mucosal Inflammation (3)
Chills (3)
Weight Decreased (3)
Nausea (3)
Therapeutic Response Decreased (3)
White Blood Cell Count Decreased (3)
Neoplasm Progression (3)
Oral Pain (2)
Peritoneal Carcinoma (2)
Pain (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Antineoplastic Side Effects Reported to FDA

The following Antineoplastic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Antineoplastic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Feeling Cold
on Apr 02, 2012 Male from UNITED STATES , 57 years of age, was treated with Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: feeling cold. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Leukine (Unk)


Injection Site Pruritus
Patient was taking Antineoplastic Agents. Patient felt the following Antineoplastic side effects: injection site pruritus on May 31, 2012 from UNITED STATES Additional patient health information: Male , 71 years of age, . Antineoplastic Agents dosage: N/A.
Multiple prescriptions taken:
  • Leukine (250 ?g, Tiw)


Pneumonia
Adverse event was reported on Jun 14, 2012 by a Female taking Antineoplastic Agents (Dosage: N/A) was diagnosed with and. Location: FRANCE , 30 years of age, After Antineoplastic was administered, patient encountered several Antineoplastic side effects: pneumonia.
Multiple concurrent drugs taken:
  • Neulasta
Patient was hospitalized.

Interstitial Lung Disease, Respiratory Failure, Dyspnoea, Pyrexia
on Jun 04, 2012 Female from JAPAN , 71 years of age, weighting 77.16 lb, was treated with Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: interstitial lung disease, respiratory failure, dyspnoea, pyrexia. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Omeprazole
  • Rebamipide
  • Zometa
  • Maglax
  • Therapeutic Radiopharmaceuticals
  • Vitamin B12
  • Loxoprofen
  • Docetaxel (80 Mg/4 Ml)



Hepatitis Toxic, Blood Bilirubin Increased, Jaundice, Abdominal Distension, Chromaturia, Transaminases Increased, Deficiency Of Bile Secretion
on May 30, 2012 Male from SPAIN , 62 years of age, weighting 174.2 lb, was treated with Antineoplastic Agents. Patient felt the following Antineoplastic side effects: hepatitis toxic, blood bilirubin increased, jaundice, abdominal distension, chromaturia, transaminases increased, deficiency of bile secretion. Antineoplastic Agents dosage: N/A.
Multiple prescriptions taken:
  • Primovist (Unk)


Neoplasm Malignant
Patient was taking Antineoplastic Agents. After Antineoplastic was administered, patient encountered several Antineoplastic side effects: neoplasm malignant on May 22, 2012 from BRAZIL Additional patient health information: Male , 52 years of age, weighting 121.3 lb, was diagnosed with and. Antineoplastic Agents dosage: N/A.
Multiple concurrent drugs taken:
  • Granulokine (Unk)


Myelocytosis
Adverse event was reported on May 22, 2012 by a Female taking Antineoplastic Agents (Dosage: N/A) was diagnosed with and. Location: FRANCE , 58 years of age, Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: myelocytosis.
Associated medications used:
  • Neulasta


Abscess
on Nov 01, 2011 Female from ISRAEL , 44 years of age, was diagnosed with and was treated with Antineoplastic Agents. Patient felt the following Antineoplastic side effects: abscess. Antineoplastic Agents dosage: Unk Unk, Q3wk.
Multiple prescriptions taken:
  • Neulastim (Unk Unk, Q3wk)
Patient was hospitalized.

Therapeutic Response Decreased, Mantle Cell Lymphoma
on May 05, 2012 Female from UNITED STATES , 72 years of age, was diagnosed with and was treated with Antineoplastic Agents. After Antineoplastic was administered, patient encountered several Antineoplastic side effects: therapeutic response decreased, mantle cell lymphoma. Antineoplastic Agents dosage: Unk.
Multiple concurrent drugs taken:
  • Nplate


Dyspnoea, Confusional State, Coordination Abnormal, Muscular Weakness
Patient was taking Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: dyspnoea, confusional state, coordination abnormal, muscular weakness on Apr 04, 2012 from UNITED KINGDOM Additional patient health information: Female , 68 years of age, . Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Rifampicin
  • Rifampicin
Patient was hospitalized.

Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase Increased
Adverse event was reported on Apr 05, 2012 by a Female taking Antineoplastic Agents (Dosage: Unk) . Location: GERMANY , 55 years of age, weighting 149.9 lb, Patient felt the following Antineoplastic side effects: decreased appetite, neoplasm progression, weight decreased, blood alkaline phosphatase increased.
Multiple prescriptions taken:
  • Xgeva (120 Mg, Q4wk)
  • Ibuprofen (600 Mg, Tid)


Febrile Neutropenia, Infection
on Mar 30, 2010 Female from UNITED STATES , 62 years of age, was diagnosed with and was treated with Antineoplastic Agent (no Ingredients/substances). After Antineoplastic was administered, patient encountered several Antineoplastic side effects: febrile neutropenia, infection. Antineoplastic Agent (no Ingredients/substances) dosage: N/A.
Multiple concurrent drugs taken:
  • Gleevec (600 Mg, Qd, Oral)
Patient was hospitalized.

Arthralgia, Fractured Sacrum
on Apr 04, 2012 Female from UNITED STATES , 52 years of age, was diagnosed with and was treated with Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: arthralgia, fractured sacrum. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Neulasta (6 Mg, Unk)


Syncope, Dysstasia, Dizziness
Patient was taking Antineoplastic Agents. Patient felt the following Antineoplastic side effects: syncope, dysstasia, dizziness on Apr 02, 2012 from UNITED STATES Additional patient health information: Male , 76 years of age, . Antineoplastic Agents dosage: Unk.
Multiple prescriptions taken:
  • Aranesp (300 Mug, Q3wk)


Confusional State, Muscular Weakness, Coordination Abnormal, Dyspnoea
Adverse event was reported on Mar 27, 2012 by a Female taking Antineoplastic Agents (Dosage: N/A) . Location: UNITED KINGDOM , 68 years of age, After Antineoplastic was administered, patient encountered several Antineoplastic side effects: confusional state, muscular weakness, coordination abnormal, dyspnoea. Patient was hospitalized.

Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase Increased
on Mar 29, 2012 Female from GERMANY , 55 years of age, weighting 149.9 lb, was treated with Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: decreased appetite, neoplasm progression, weight decreased, blood alkaline phosphatase increased. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Xgeva (120 Mg, Q4wk)
  • Ibuprofen (600 Mg, Tid)


Muscular Weakness, Confusional State, Dyspnoea, Coordination Abnormal, Mycobacterium Tuberculosis Complex Test Positive
on Mar 26, 2012 Female from UNITED KINGDOM , 68 years of age, was treated with Antineoplastic Agents. Patient felt the following Antineoplastic side effects: muscular weakness, confusional state, dyspnoea, coordination abnormal, mycobacterium tuberculosis complex test positive. Antineoplastic Agents dosage: N/A.
Multiple prescriptions taken:
  • Ethambutol Hydrochloride
Patient was hospitalized.

Coordination Abnormal, Confusional State, Muscular Weakness, Dyspnoea
Patient was taking Antineoplastic Agents. After Antineoplastic was administered, patient encountered several Antineoplastic side effects: coordination abnormal, confusional state, muscular weakness, dyspnoea on Mar 16, 2012 from UNITED KINGDOM Additional patient health information: Female , 68 years of age, . Antineoplastic Agents dosage: N/A. Patient was hospitalized.

Leukocytosis
Adverse event was reported on Mar 19, 2012 by a Female taking Antineoplastic Agents (Dosage: N/A) was diagnosed with and. Location: UNITED STATES , 80 years of age, Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: leukocytosis.
Associated medications used:
  • Neulasta (6 Mg, Per Chemo Regim)


Psychotic Disorder
on Mar 06, 2012 Female from NETHERLANDS , 50 years of age, was diagnosed with and was treated with Antineoplastic Agents. Patient felt the following Antineoplastic side effects: psychotic disorder. Antineoplastic Agents dosage: N/A.
Multiple prescriptions taken:
  • Neulasta (6 Mg, Unk)


Malaise
on Dec 15, 2011 Female from UNITED STATES , 53 years of age, was diagnosed with and was treated with Antineoplastic Agents. After Antineoplastic was administered, patient encountered several Antineoplastic side effects: malaise. Antineoplastic Agents dosage: Unk.
Multiple concurrent drugs taken:
  • Xgeva (120 Mg, Unk)


Dehydration, Nausea, Rash, Hyperhidrosis
Patient was taking Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: dehydration, nausea, rash, hyperhidrosis on Mar 01, 2012 from NETHERLANDS Additional patient health information: Female , 50 years of age, was diagnosed with and. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Neulasta (6 Mg, After Chemo)
Patient was hospitalized.

Brain Cancer Metastatic
Adverse event was reported on Feb 22, 2012 by a Female taking Antineoplastic Agents (Dosage: Form: Vial) . Location: GUATEMALA , 66 years of age, weighting 153.2 lb, Patient felt the following Antineoplastic side effects: brain cancer metastatic.
Multiple prescriptions taken:
  • Lantus


Confusional State, Muscular Weakness, Coordination Abnormal, Dyspnoea
on Feb 21, 2012 Female from UNITED KINGDOM , 68 years of age, was treated with Antineoplastic Agents. After Antineoplastic was administered, patient encountered several Antineoplastic side effects: confusional state, muscular weakness, coordination abnormal, dyspnoea. Antineoplastic Agents dosage: N/A.
Multiple concurrent drugs taken:
  • Rifampicin
Patient was hospitalized.

Chills, Hypokalaemia, Tubulointerstitial Nephritis, Depressed Level Of Consciousness, White Blood Cell Count Increased, Blood Cortisol Decreased, Leukocyturia, Hypopituitarism, Renal Impairment
on Feb 21, 2012 Female from JAPAN , weighting 108.0 lb, was treated with Antineoplastic Agents. Directly after, patient experienced the unwanted or unexpected Antineoplastic side effects: chills, hypokalaemia, tubulointerstitial nephritis, depressed level of consciousness, white blood cell count increased, blood cortisol decreased, leukocyturia, hypopituitarism, renal impairment. Antineoplastic Agents dosage: N/A.
Associated medications used:
  • Vitamin D (Unk Ukn, Unk)
  • Ts 1 (60 Mg, Unk)
  • Zometa (4 Mg, Qmo)
  • Vitamin D
  • Spiriva
  • Medroxyprogesterone Acetate (400 Mg, Unk)


1 of 3 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Antineoplastic Side Effects

    Did You Have a Antineoplastic Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Antineoplastic for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Antineoplastic

    Side Effects reported to FDA: 73

    Antineoplastic safety alerts: No

    Reported deaths: 21

    Reported hospitalizations: 32

    Latest Antineoplastic clinical trials

    Antineoplastic Reviews

    No reviews, be a first to report a side effect via side effect reporting form